Smith Group Asset Management’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-840
Closed -$20K – 453
2019
Q1
$20K Hold
840
– – ﹤0.01% 377
2018
Q4
$19K Sell
840
-7
-0.8% -$168 ﹤0.01% 376
2018
Q3
$22K Hold
847
– – ﹤0.01% 382
2018
Q2
$23K Buy
847
+52
+7% +$1.38K ﹤0.01% 382
2018
Q1
$21K Hold
795
– – ﹤0.01% 394
2017
Q4
$22K Hold
795
– – ﹤0.01% 397
2017
Q3
$18K Hold
795
– – ﹤0.01% 412
2017
Q2
$21K Sell
795
-2
-0.3% -$53 ﹤0.01% 402
2017
Q1
$22K Hold
797
– – ﹤0.01% 385
2016
Q4
$20K Sell
797
-3
-0.4% -$63 ﹤0.01% 386
2016
Q3
$18K Hold
800
– – ﹤0.01% 391
2016
Q2
$15K Hold
800
– – ﹤0.01% 414
2016
Q1
$21K Sell
800
-50
-6% -$1.16K ﹤0.01% 359
2015
Q4
$22K Buy
+850
New +$22.9K ﹤0.01% 381

Other funds holding TBI

Smith Group Asset Management's TBI Position: Q2 2019 in Review

Smith Group Asset Management sold out of Trueblue (TBI) in Q2 2019, closing a stake of 840 shares — an estimated $20K sold.

Smith Group Asset Management first reported a position in TBI in Q4 2015 and held it in 14 quarters. The position peaked at $23K in Q2 2018. 185 funds tracked by Wall St. Rank hold TBI as of Q2 2019.

  • Smith Group Asset Management reported no remaining Trueblue position as of Q2 2019 after selling out during the quarter.
  • Smith Group Asset Management sold 840 Trueblue shares in Q2 2019, an estimated $20K.
  • Smith Group Asset Management first reported a position in Trueblue in Q4 2015 and held it in 14 quarters.
  • Smith Group Asset Management's Trueblue position peaked at $23K in Q2 2018.
  • 185 funds tracked by Wall St. Rank held Trueblue as of Q2 2019.

Based on Smith Group Asset Management's 13F filing for Q2 2019, filed 8 Aug 2019.